Ceragenix and Davi Enter Into Distribution and Supply Agreement for EpiCeram[R].

Business WireMay 19, 2009

Linked as:

Extract


Ceragenix and Davi Enter Into Distribution and Supply Agreement for EpiCeram[R].

Davi to Register, Distribute and Market in Europe.

DENVER -- Ceragenix Pharmaceuticals, Inc.("Ceragenix") (OTCBB:CGXP), a medical device company focused on infectious disease and dermatology today announced that it has entered into an exclusive distribution and supply agreement (the "Agreement") with Davi II - Farmaceutica S.A., a Portuguese company, ("Davi "), to commercialize ...

See the full content of this document

Sponsored links




ver las páginas en versión mobile | web

ver las páginas en versión mobile | web

© Copyright 2012, vLex. All Rights Reserved.

Contents in vLex United States

Explore vLex

For Professionals

For Partners

Company